Amgen R&D decreased by 19.7% to $1.72B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.7%, from $1.49B to $1.72B. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 10.8% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
Metric ID:
research_and_developmentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.08B | $1.42B | $1.35B | $959.00M | $1.04B | $1.11B | $1.32B | $1.06B | $1.11B | $1.08B | $1.53B | $1.34B | $1.45B | $1.45B | $1.72B | $1.49B | $1.74B | $1.90B | $2.14B | $1.72B |
| QoQ Change | — | +31.4% | -5.2% | -28.9% | +8.3% | +7.0% | +19.1% | -20.1% | +5.2% | -3.1% | +42.2% | -12.5% | +7.7% | +0.2% | +18.9% | -13.8% | +17.4% | +8.9% | +12.7% | -19.7% |
| YoY Change | — | — | — | — | -4.0% | -21.8% | -1.8% | +10.3% | +7.1% | -3.0% | +15.9% | +26.9% | +30.0% | +34.4% | +12.4% | +10.6% | +20.5% | +31.0% | +24.2% | +15.7% |
Range$959.00M – $2.14B
CAGR+10.2%
Avg YoY Growth+13.0%
Median YoY Growth+14.0%
R&D at Other Companies
Frequently Asked Questions
- What is Amgen's r&d?
- Amgen (AMGN) reported r&d of $1.72B in Q1 2026.
- How has Amgen's r&d changed year-over-year?
- Amgen's r&d increased by 15.7% year-over-year, from $1.49B to $1.72B.
- What is the long-term trend for Amgen's r&d?
- Over 4 years (2021 to 2025), Amgen's r&d has grown at a 10.8% compound annual growth rate (CAGR), from $4.82B to $7.27B.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.